<
https://apnews.com/article/epipen-nasal-spray-allergic-reaction-fda-32ef474cbe0a14bc854691ec44bbaf10>
"U.S. health officials on Friday approved a nasal spray to treat severe
allergic reactions, the first needle-free alternative to shots like EpiPen.
The Food and Drug Administration said it approved the spray from drugmaker ARS
Pharmaceuticals Inc. as an emergency treatment for adults and older children
experiencing life-threatening allergic reactions known as anaphylaxis.
Anaphylaxis occurs when the body’s immune system develops a sudden, unexpected
reaction to a foreign substance, such as food, insect stings or medications.
Common symptoms include hives, swelling, itching, vomiting and difficulty
breathing.
The device, marketed as Neffy, could upend treatment for the 33 million to 45
million Americans with severe allergies to food and other triggers. Anaphylaxis
sends more than 30,000 people to emergency rooms and results in more than 2,000
hospitalizations and more than 230 deaths in the U.S. each year.
Of the 6 million prescriptions written for auto-injectors each year, more than
40% are never filled, Dr. Thomas Casale, an allergist at the University of
South Florida, told an FDA advisory panel last year. Even when they are
available to caregivers, many auto-injectors are used incorrectly, he said."
Via
What Could Go Right?: Opioid Deaths Are Finally Falling
https://theprogressnetwork.org/opioid-deaths-decline/
Cheers,
*** Xanni ***
